Characterisation of a synergistic interaction between a thymidylate synthase inhibitor, ZD1694, and a novel lipophilic topoisomerase I inhibitor karenitecin, BNP1100: mechanisms and clinical implications

This publication has 32 references indexed in Scilit:

• Expression of the MRP and MDRI Multidrug Resistance Gene Products in 160 Untreated Human Carcinomas Studied by Immunohistochemical Methods in Formalin-Paraffin Sections
  International Journal of Surgical Pathology, 1998
• Irinotecan and 5-Fluorouracil in colorectal cancer: time for a pause?
  European Journal Of Cancer, 1998
• Mechanism of Action of Camptothecin
  Annals of the New York Academy of Sciences, 1996
• The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996
  Critical Reviews in Oncology/Hematology, 1996
• Thymidylate synthase inhibition, a dead end?
  European Journal Of Cancer, 1995
• DNA recombinase activity of eukaryotic DNA topoisomerase I; effects of camptothecin and other inhibitors
  Mutation Research/DNA Repair, 1995
• CPT-11 (Irinotecan) in the treatment of colorectal cancer
  European Journal Of Cancer, 1995
• New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
  JNCI Journal of the National Cancer Institute, 1990
• Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug Synergism
  Science, 1979
• Quantitative conservation of chromatin-bound RNA polymerases I and II in mitosis. Implications for chromosome structure.
  The Journal of cell biology, 1979